MDxHealth SA
MDXH
$3.55
$0.082.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.67% | 6.40% | 15.48% | -5.98% | -25.99% |
| Total Depreciation and Amortization | 11.82% | -10.36% | 17.22% | 68.36% | 105.03% |
| Total Amortization of Deferred Charges | 119.53% | 158.04% | -63.59% | -63.59% | -63.59% |
| Total Other Non-Cash Items | -8.90% | 9.96% | 41.51% | 64.90% | 197.76% |
| Change in Net Operating Assets | -82.41% | -206.83% | -789.57% | -1,701.62% | 34.88% |
| Cash from Operations | 13.80% | 4.45% | 25.82% | 2.37% | 22.33% |
| Capital Expenditure | 56.75% | 63.98% | 65.65% | 17.77% | -12.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 109.07% | 54.83% | 23.92% | 11.68% | -0.43% |
| Cash from Investing | 58.34% | 61.19% | 91.77% | 88.57% | 86.27% |
| Total Debt Issued | -- | 5,065.63% | 55.60% | -- | -- |
| Total Debt Repaid | -1,167.15% | -1,595.81% | -250.74% | 70.62% | 71.93% |
| Issuance of Common Stock | 2.88% | -6.04% | -100.00% | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -90.65% | -71.51% | -102.88% | -150.58% | -258.76% |
| Cash from Financing | 38.18% | 20.33% | -90.53% | -112.77% | 50.02% |
| Foreign Exchange rate Adjustments | -156.00% | -95.56% | 163.61% | 120.71% | 109.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 255.07% | 209.73% | -3,178.12% | -510.26% | 119.64% |